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The role of endovascular therapy in acute mesenteric ischemia
Anna Maria Ierardia, Dimitrios Tsetisb, Sara Sbarainia, Salvatore Alessio Angileria, Nikolaos Galanakisb, 
Mario Petrilloa, Francesca Patellaa, Silvia Panellaa, Federica Balestraa, Natalie Lucchinac, 
Gianpaolo Carrafielloa
University of Milan, San Paolo Hospital, Milan, Italy; University Hospital of Heraklion, School of Medicine, University 
of Crete, Crete, Greece; University of Insubria, Varese, Italy
Background Endovascular therapy, including aspiration thrombectomy and local thrombolytic 
therapy, often associated with angioplasty and stent placement, has been described in the literature. 
The purpose of this study was to review case series of patients with acute mesenteric ischemia 
treated with endovascular therapy and evaluate their outcomes.
Methods An online  review  using PubMed was carried out to identify all English articles 
about this topic in the time interval from 2005 to 2016. The following variables were extracted: 
number of patients, cause of occlusion, symptoms, arteries involved, number of sessions of 
treatment, technical success, clinical success, recurrence rate, complications, mortality rate, 
number of patients who underwent diagnostic laparoscopy or surgical resection of ischemic 
bowel.
Results Eighteen papers met the inclusion criteria and were included. Among the patients with 
arterial mesenteric ischemia treated with endovascular approach, the technical success rate was 
high (up to 100%) and data regarding clinical success are encouraging, even though they are 
few and heterogeneous. Technical success rate and clinical success of patients with acute venous 
mesenteric ischemia approached with endovascular treatment was 74-100% and 87.5-100% 
respectively.
Conclusions Current advances in endovascular therapies have made these treatments feasible for 
mesenteric ischemia.
Keywords Acute venous/arterial ischemia, interventional radiology, endovascular recanalization, 
thrombolysis, thromboaspiration
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Introduction
Vascular pathologies of the small and large bowel can be 
of venous or arterial etiology. Mesenteric ischemia is classified 
as acute (caused by thromboembolism or hypoperfusion) or 
chronic. The development of imaging technology has gradually 
increased the diagnostic rate of venous or arterial mesenteric 
ischemia. The standard care used to be open surgical repair, 
but in the last 15  years the development of endovascular 
procedures has introduced a minimally invasive treatment 
option [1]. In both chronic and acute settings, angioplasty and 
stenting have been successfully described for management of 
stenoses or occlusions [2].
Nowadays, apart from percutaneous transluminal 
angioplasty (PTA) and stenting, other endovascular techniques 
are available, including the use of intra-arterial thrombolysis, 
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vasodilators and suction embolectomy. Endovascular therapy 
can potentially modify clinical outcomes in patients with acute 
bowel ischemia; however, given the relative infrequency of this 
disease, it is hard to obtain wide experience over a relatively 
short interval and only small case series are available in the 
literature.
The objective of this study was to review the management 
of acute mesenteric ischemia (AMI) with endovascular 
procedures and to determine the efficacy and recanalization 
rates, the incidence of complications, and the mortality, in 
order to provide an update on the current concepts in the 
management of this disease.
Materials and methods
Search and selection process
A comprehensive search of the English-language published 
literature was carried out through PubMed to identify all 
articles reporting acute arterial and venous mesenteric 
ischemia treated by endovascular therapy. The research was 
performed using the following medical subject headings 
(MeSH): “endovascular therapy and acute arterial mesenteric 
ischemia”, “endovascular therapy and mesenteric infarction”, 
“endovascular therapy and interventional radiology and acute 
mesenteric ischemia”, “endovascular recanalization and acut 
mesenteric ischemia”, “thrombolysis and thromboaspiration 
and acute mesenteric ischemia”, “stenting and angioplasty and 
acute mesenteric ischemia”, “endovascular therapy and acute 
venous mesenteric ischemia and occlusion”, “acute venous 
mesenteric ischemia and interventional radiology”, “acute 
venous mesenteric ischemia and endovascular recanalization”, 
“acute venous mesenteric ischemia and thrombolysis and 
thromboaspiration”.
At the first stage, only titles and abstracts were reviewed to 
select articles focusing on patients with AMI who had venous 
or arterial occlusion treated with endovascular therapies. Case 
reports, small series revisions and papers that contained data 
reported previously were excluded. At the second stage, all 
articles selected were reviewed in their full text version.
Articles were considered eligible for inclusion in the present 
review if at least one outcome of interest was described. 
In studies involving patients treated with a surgical or 
endovascular approach, only those treated by endovascular 
therapy were extracted. Additional studies were identified 
through manual research of the bibliographies from primary 
studies, review articles, and key journals.
Data extraction and analysis
Patients were assigned to acute arterial or acute venous 
ischemia groups, according to the nature of the mesenteric 
ischemia. The following variables were extracted, when 
available, from the included articles: number of patients, cause 
of occlusion, symptoms, arteries involved, number of sessions 
of treatment, technical success, clinical success, recurrence 
rate, complications, mortality rate, number of patients who 
underwent diagnostic laparoscopy or surgical resection of 
ischemic bowel. Data are reported as described in the studies: 
authors sometimes reported a range and/or a median value; 
sometimes a rate and/or a value is reported. Information not 
mentioned was classified as not available.
Before the extraction of data from the eligible studies, the 
following clear definitions of all outcomes of interest were 
established. Clinical success was defined as the frequency 
of successful treatment in each study. Technical success was 
defined as the restoration of flow in the treated vessels and 
their branches on the final angiogram, without any need for 
further re-intervention (endovascular or vascular surgical 
intervention), as clearly mentioned in each manuscript. 
Sometimes, particularly in acute thrombolysis, more sessions 
were necessary: in this latter case the final result was reported. 
Mortality was defined as early death before discharge due 
to persistent ischemia, complications related to persistent 
ischemia, or hemorrhagic complications related to massive 
anticoagulant therapy.
Results
Eighteen papers met the inclusion criteria and were 
included in this systematic review. All the data collected by 
12 studies focusing on acute arterial mesenteric ischemia are 
summarized in Table 1 [2-14], and the data obtained from 6 
papers focusing on acute venous mesenteric ischemia are 
presented in Table 2 [15-20]. In Tables we analyzed all studies 
published during the selected period (2005-2016).
Endovascular treatment of acute arterial mesenteric 
ischemia
AMI was predominantly caused by arterial emboli from 
cardiac arrhythmias (40-50%), thrombosis at preexisting 
lesions (25%) and other non-occlusive causes. The 
superior mesenteric artery (SMA) is the commonest site of 
thromboembolic occlusion, because of its oblique origin from 
the aorta [21]. Abdominal pain, vomiting and nausea were the 
most common presenting symptoms.
On the basis of the data in Table  1 [2-14], the technical 
success rate is high (up to 100%) and data regarding clinical 
success are encouraging, even though they are few and 
heterogeneous. The main reason for these different results is 
the heterogeneity of patients and their characteristics (age, 
clinical history, performance status, etc.) from center to 
center.
The study of Arthurs et al [8] represents the largest series 
of patients with AMI treated with endovascular therapy 
in one center. The investigators excluded patients with 
mesenteric venous thrombosis, non-occlusive mesenteric 
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ischemia or ischemia associated with aortic dissection. They 
retrospectively evaluated 70  patients with AMI in whom 
endovascular revascularization was the preferred treatment 
(81%). The primary technique was thrombolysis infusion, 
which was used in 48% of the population. Thirty-two percent 
of patients were treated with primary PTA and stenting. 
Aspiration thrombectomy in conjunction with thrombolysis 
was performed in 12% of patients. Successful endovascular 
treatment was achieved in 87% of cases, and the mortality rate 
was 36%, compared with 50% (P<0.05) in patients treated with 
traditional therapy.
Acute renal failure, myocardial and cerebral infarctions, 
bowel ischemia and short bowel syndrome are the most 
common complications reported in literature.
Potential complications related to the endovascular 
procedure include access-related bleeding (e.g.  hematoma, 
pseudoaneurysm) and vessel trauma that can lead to arterial 
dissection or atheroembolization. The use of distal embolic 
protection devices may mitigate the risk of bowel necrosis as a 
consequence of distal embolization, but there is a lack of data 
concerning their efficacy in the mesenteric circulation.
Endovascular treatment of acute venous mesenteric 
ischemia
Among the cases of AMI, mesenteric vein thrombosis 
(MVT) has an incidence of 6-9%, and the vein mainly involved 
is the superior mesenteric vein (SMV) [22].
In Table 2 [15-20] we present the literature from patients 
treated via an endovascular approach. So far, only small series 
are available; only a little over 100 patients have been treated. 
In the majority of published case series, the primary treatment 
was local thrombolysis; Wichman et al [18] treated 8 patients 
with symptomatic portomesenteric venous occlusion, using 
endovascular procedures such as aspiration thrombectomy, 
thrombolysis and stent placement.
On the basis of the few data available, the technical success 
rate has been reported to be between 74% and 100%. When 
reported, the clinical success rate is high (87.5-100%), with a 
low recurrence rate.
The most common complication is hemorrhage; some cases 
of sepsis were also described.
In most cases a surgical revision was performed and in 
some cases bowel resection was necessary.
Discussion
A key goal of endovascular therapy in AMI is to rapidly 
reestablish flow into the proximal arterial segments. The most 
appropriate therapy should be tailored according to the clinical 
symptoms, laboratory values and computed tomography (CT) 
findings. In some studies, primary endovascular therapy is 
applied with on-demand laparotomy for patients with mild or 
moderate clinical or laboratory signs of peritonitis [14]. Under 
these conditions, thrombolysis is associated with a greater risk 
of major bleeding from necrotic bowel. Thrombolytic therapy 
also increases the risk of potential early surgical revision. These 
represent the main reasons why adjunctive therapy was not 
applied in some studies. Series in which patients presented with 
early mesenteric ischemia recommend thrombolysis. Despite 
modern advances in current medicine, the early diagnosis of 
intestinal ischemia is still very difficult. In our daily practice, we 
often encounter patients with advanced mesenteric ischemia.
The most common percutaneous methods for AMI are 
aspiration thrombectomy, in which thrombus/embolus is 
removed by suction, and mechanical thrombectomy, using 
different automated devices for the fragmentation and 
removal of embolus [23]. Mechanical thrombectomy involves 
aspiration of embolus and massive thrombosis using a 6-Fr 
guiding catheter. Other thrombectomy techniques include: 
mechanical removal of the thrombus with the Rotarex system 
(Straub Medical AG, Wangs, Switzerland) or the Penumbra 
system [24], thrombolysis with a rheolytic system [25], or 
pharmacologic thrombolysis using the EKOS catheter [26,27]. 
Catheter-directed thrombolysis with urokinase is 
utilized if aspiration thrombectomy did not resolve the 
thrombus [28-30,13].
Balloon angioplasty is an alternative technique for clot 
fragmentation in cases of resistant thrombus. Published cases 
using percutaneous thrombectomy, with or without PTA, are 
rather low in number, but the results seem encouraging [31,32].
After removal of a thrombotic clot by aspiration, 
thrombolysis or angioplasty, treatment of the underlying 
stenotic or occlusive lesions can be achieved during the same 
session. Angioplasty and stenting, if performed early, have 
been shown to prevent intestinal infarction and obviate the 
need for laparotomy [33,34]. The hybrid approach facilitates 
endovascular intervention and represents a useful technique 
for the management of patients with AMI who require 
emergency laparotomy [35,36].
Wyers et al [3] drew attention to the benefits of combining 
laparotomy (direct bowel examination to confirm viability) 
with endovascular intervention (avoid the need for bypass 
grafting), particularly for patients who would otherwise require 
open surgical revascularization.
In cases of embolism, after the initial aspiration has 
failed, Raupach et al [14] currently tend to use direct surgical 
embolectomy of the SMA trunk and resection of necrotic 
bowel parts. This approach saves time and prevents a delayed 
diagnosis of bowel necrosis.
Acute embolic occlusion seems to be more suitable for 
thrombolytic therapy than thrombotic occlusions, because 
emboli typically are dislodged to the periphery of the SMA 
in an atherosclerosis-free segment and local pharmacologic 
thrombolysis has the potential to dissolve the clot completely, 
with minimal trauma to the occluded artery [37] (Fig. 1, A, B, C).
Successful recanalization does not preclude laparotomy to 
check or resect the intestine. Dead bowel has to be resected 
before the patient falls into profound septic shock [36].
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Table 1 Acute mesenteric arterial ischemia
Study N° 
patients
Cause occlusion Symptoms Arteries 
involved
Primary treatment
Emboli Thrombosis Other Thrombolysis Thrombectomy PTA/stent
Lim 2005 [2] 3 0% 33%
(1)
66% 
(2)
Acute abdominal pain 
100%, Nausea 33%, 
Vomiting 33%, Diarrhea 
33%, Hematemesis 33%, 
Melena 33%
SMA 33%
(1)
0% 66% (2)
Wyers 2007 [3] 2 0% 100% 0% NS SMA NS NS 100%
Acosta 2009 [4] 21 48%
(10)
52%
(11)
0% NS SMA 10%
(2)
38%
(8)
24%
(5)
Schermerhorn 
(2000-2006)
2009 [5]
1857 NS NS NS 0% 0% 100%
Block 2010 [6] 42 29%
(12)
62%
(26)
9%
(4)
Abdominal pain, Vomiting, 
Diarrhea, Hematochezia
SMA NS
Bjornsson 2011 [7] 34 82% 
(28)
18%
(6)
0% Acute abdominal pain 30% 
(10), Sudden abdominal 
pain 36% (12), Bloody 
stools 3% (1), Diarrhea 36% 
(12), Vomiting 62% (21), 
Atrial fibrillation 62% (21)
SMA 100% 0% 0%
Arthurs 2011 [8]  56 35% 65% 0% Abdominal pain 92%, 
Nausea 69%, Emesis 51%, 
Bloody diarrhea 31%
SMA 66% 
SMA+ 
celiac artery 
34%
48% 11% 32%
Ryer* 2012 [9] 11 31%
(29)
54%
(50)
0-6% Abdominal pain 
(91-98%), Abdominal 
tenderness (58-79%), 
Diarrhea (38-23%), 
Nausea (42-38%), Vomiting 
(36-27%), LGIB (16-13%)
SMA +- 
celiac artery
67%
(2)-25% (2)
0-13% 33%
(1)- 
62.5%
(5)
Beaulieu 2014 [10] 165 NS NS NS Lactic acidosis 11.4%, 
ARDS 7%, SIRS 5.9%, 
Hypotension 4.9%
NS NS
Jia 20 14 [11] 21 NS NS NS Abdominal pain and no 
evidence of advanced bowel 
ischemia sign
SMA 0% 100% 0%
   Barrera 2015 [12] 9 33% 45% 22% No peritoneal irritation Small 
intestine
18% NS NS
   Karkkainen 2015 [13] 50 36% 
(18)
64% (32) 0% Abdominal pain 94%,
Abdominal distension 26%,
Diarrhea 48%,
Vomiting 56%,
Paralytic ileus 20%,
GI bleeding 14%,
Acute kidney injury 6%,
Clinical features of 
peritonitis 14%
SMA
SMA + 
celiac artery
SMA + IMA
0% 40% (20) 60% (30)
   Raupach 2016 [14] 37 100% 0% 0% Abdominal pain Diarrhea, 
Bloody diarrhea, Nausea, 
Emesis
SMA 0% 100% 0%
*1990s-2000s
PTA, percutaneous transluminal angioplasty; LPT, laparotomy; LPS, laparoscopy; NS, not specified; SMA, superior mesenteric artery; ET, endovascular therapy; 
TIA, transient ischemic Attack; GI, gastrointestinal; ARDS, acute respiratory disease syndrome; SIRS, systemic inflammatory response syndrome
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Table 1: (Continued)
Secondary treatment Technical 
succ
Clinical 
succ
Recurrence 
rate
Complications Mortality Lpt/Lps and/or resection
Thrombolysis Thrombectomy PTA/Stent LPT LPS Resection
NS 100% (3) 66% (2) 0% Ischemic hepatitis 33% (1)
Acute renal failure 33% (1)
Malnutrition 33% (1)
0% 33% (1) 0% 33% (1)
NS 100% NS NS NS 100% 0% 0% 100%
25%
(2) 
NS NS NS NS NS SMA dissection
distal emboli in arterial branch
14%
(3)
67%
(14)
8%
(1)
43% (9)
NS NS NS NS Acute renal failure 11.4%,
Acute myocardial infarction 5%,
Cardiac 2.1%
Stroke 1%,
Peripheral vascular 0.5%,
respiratory 1.1%
Hemorrhage 2.4%
16% NS NS 28%
NS 79% NS NS Groin hematoma (2)
Renal embolization (1)
Femoral artery occlusion (1)
27% 73% (27) 0% 40.5%
(15)
0% 35.2%
(12)
8.8%
(3)
88% NS NS Bleeding complication 15% (5) 26% (9) 38% (13) 0% 24%(8)
0% 12%
(of 
thrombolysis)
33%
(of thrombolysis) 
22%
(of thrombectomy)
87% NS NS Acute renal failure 27%
pulmonary failure 27%
Myocardial infarction 2%
GI bleeding 7%
36% ET 
success
50% ET 
failure
31% NS NS
NS NS NS 1% Overall 73-63%
Pulmonary 16-32%
Renal 12%
Neurologic 
(TIA/stroke) 5-2%
GI 7-26%
17%-27% 63% (7) NS 45% (5)
NS NS Survival 
39.9%
NS NS 24.9% NS NS 14.4%
28.6% (6) NS NS Cerebral 
infarction 
5% (1) 
short 
bowel 
syndrome 
5% (1)
9.5% (2) 29% (6) NS 24% (5) - - -
NS 33.3% (3/9) ET+Chir 67% (6) NS NS NS NS 33.3% (3) NS NS 33.3% (3)
NS 88% (44) NS NS Access site bleeding 4% (2),
Intra abdominal bleeding 2% (1),
New GI bleeding
10% (5),
Stroke 2% (1),
Myocardial infarction 4% (2)
Heart failure 12% (6)
Acute kidney injury 8% (4)
Pulmonary failure 4% (2)
30% 40% NS 34%
5% (2) 0% 5% (2) 91.9% NS NS Groin hematoma 5.4% (2)
Renal embolization 3% (1)
Femoral artery occlusion 3% (1)
27% 73% (27) NS 40.5% (15)
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Endovascular treatment of acute venous mesenteric 
ischemia
Despite the lack of specific biomarkers or any insidious 
symptomatology profile, the incidence of acute superior 
mesenteric venous thrombosis (ASMVT) has increased 
in relation to the spread of contrast-enhanced CT; the 
portography phase facilitates early diagnosis with over 90% 
sensitivity [38].
As the overall mortality is still high (13-50% with traditional 
anticoagulation and bowel resection), the management of 
ASMVT remains a great clinical challenge [15]. In the literature, 
mortality ranged from 29-38% for surgical treatment and from 
13-19% for non-operative management [39].
Systemic anticoagulation is of uncertain value, because it is 
associated with extrahepatic portal vein hypertension (25%), 
transmural bowel infarction (18%) and an elevated risk of 
bleeding [40]. In recent years, catheter-directed thrombolysis, 
combined with local anticoagulation and endovascular 
thrombectomy, has been introduced as a minimally invasive 
treatment option to dissolve thrombus and rapidly restore 
SMV flow. This procedure may be performed directly 
(percutaneous transhepatic and transjugular intrahepatic), 
or indirectly, via an SMA approach [15]. Nevertheless, 
endovascular therapy in MVT carries a significant risk of 
complications and, although it can be life-saving in cases of 
severe ischemia (intense pain, bowel swelling and edema), the 
management should usually be stepwise, starting with low-
molecular-weight heparin or heparin infusion, and followed 
Figure  1 (A) Maximum intensity projection sagittal reconstruction 
of the contrast-enhanced computed tomography revealed thrombosis 
of the superior mesenteric artery (SMA) (arrow). (B) Angiography 
confirmed complete thrombosis of the SMA, with the tip of the catheter 
for local thrombolysis localized proximally to the thrombosis (arrow). 
(C) The angiogram obtained after thrombolysis showed acceptable 
revascularization of the artery and of its branches
CBA
Table 2 Acute mesenteric venous thrombosis
Study N° patients Cause 
occlusion: 
thrombotic
Symptoms Involved veins Primary treat
Thrombolysis Thrombectomy PTA /stent
Liu, 2009 [15] 46 100% (46) NS PV, SMV 100% (46) 0% 0%
Wang
2011 [16]
12 66,6% (8) Severe/mild abdominal pain, 
Distension, Nausea, Vomiting, 
Diarrhea, Melena, Anorexia
SMV 100% 100% (12) 0% 0%
Wichman
2014 [17]
8 100% (8) Abdominal pain, Ascites, GI 
bleeding, Cholangitis
SMV =100% (8)
SMV+PV= 62.5% (5)
SMV+SV=25% (2)
12.5% (1) 50% (4)
Yang
2014 [18]
13 100% (13) NS SMV 100% 100% (13) 0% 0%
Yang*
2015 [19]
19 100% (9) Abdominal pain, Anorexia, 
Distension, Nausea, Vomiting, 
Diarrhea, Constipation, GI 
bleeding, Peritonitis, Fever
SMV= 41.86%
SMV+PV =46.51%
SMV+PV+SV=11.63%
100% (19) 0% 0%
Yang
2015 [20]
8 100% (8) Abdominal pain, Distention, 
Ascites, Lumbodorsal pain, 
Peritonitis, Constipation, Fever, 
Diarrhea, Nausea, Emesis, 
Hematemesis, Hematochezia
IVC+SMV+PV=25% (2)
SMV+PV=25% (2)
SMV+PV+SV=25% (2)
100% (8) 0% 0%
*All data refer to surgical and endovascular treatments
PTA, percutaneous transluminal angioplasty; LPT, laparotomy; LPS, laparoscopy; NS, not specified; SMV, superior mesenteric vein; PV, portal vein; SV, splenic 
vein; IVC, inferior vena cava; ARDS, acute respiratory distress syndrome; TIPS, transjugular intrahepatic portosystemic shunt
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by endovascular procedure if the patient’s condition does not 
improve or deteriorates [39,40].
Aspiration thrombectomy, combined with angioplasty 
and/or stenting, is more frequently used as a secondary 
treatment. Rapid thrombus dissolution can be achieved by 
transjugular intrahepatic portosystemic shunt to create a low-
pressure runoff in patients with acute superior mesenteric 
venous thrombosis, ascites or coagulation disorder [17].
Early detection is crucial for a correct endovascular or 
combined approach.
Emergent laparotomy is imperative with evidences 
of transmural bowel infarction and peritonitis [15]. In 
patients with no evidence of bowel infarction or perforation, 
transcatheter thrombolysis and aspiration thrombectomy may 
be proposed. Laparoscopic examination may be performed 
after initiation of thrombolytic therapy. This treatment option 
decreases the risk of short-bowel syndrome due to extensive 
bowel resection and unnecessary laparotomy, which is a bad 
prognostic factor in compromised patients.
On the basis of the heterogeneity of the studies published, the 
indications for the combination of systemic anticoagulation and 
loco-regional thrombolysis are not easily deduced; bleeding 
complications (encephalic, gastrointestinal tract, etc.) 
were observed more frequently in patients who underwent 
systemic anticoagulation after previously being treated with 
endovascular thrombolysis. Literature data and clinical practice 
show that the indication for systemic anticoagulation usually 
depends on the causes of the acute event (embolic or not) and 
in some cases it is not possible to avoid systemic therapy and 
its risks. In these patients (usually compromised and at high 
risk for further therapies) endovascular therapy represents a 
life-saving treatment [41]. Mortality is reported in almost all 
the articles examined, but the causes of death are not always 
indicated. Selection bias in the patient populations influences 
the mortality rate, which varies from center to center. There 
are no treatment protocols or international guidelines for 
AMI. Considering the low incidence, as well as the constant 
evolution of therapeutic techniques, it is hard to conduct a 
large-scale, randomized, controlled trial.
In conclusion, the analysis of the data presented here proves 
the feasibility of the endovascular procedures with encouraging 
results. Most of these studies show lower bowel morbidity and 
lower mortality after endovascular therapy compared with 
open surgery. In the future, more studies are necessary to 
assess long-term outcomes and to outline detailed indications 
regarding the type of treatment (thromboaspiration and/or 
thrombolysis) and association with systemic therapy.
Secondary treat Technical 
success
Clinical 
success
Recurrence 
rate
Complications Mortality Lpt/Lps and/or resection
Thrombolysis Thrombectomy PTA/stent LPT LPS Resection
NS NS NS 74% (34) NS 6.5% (3) NS 2% (1) NS NS 2% (1)
NS NS NS 100% 
(12)
100% (12) 0% Small hematoma at puncture site 
25% (3)
0% NS
37.5% (3) 0% 7 SMV
6 PV
2 SV
4 TIPS
100% (8) 87.5% (7) NS Splenic hemorrhage 12.5% (1)
Mesenteric vein perforation 
12.5% (1)
12.5% 
(1)
NS
NS NS NS 84.6% 
(11)
NS 0% 0% 0% NS 30.7% 
(4)
30.7% (4)
0% 51% (22) 14% (6) 79%
94,44%
NS 7% (3) Sepsis 18.6% (8)
Acute compartmental Syndrome 
11.6% (5)
Pneumonia 18.6% (8)
ARDS 11.6% (5)
Acute kidney injury 16.3% (7)
Recurrent ischemia 9.3% (4)
GI bleeding 11.6% (5)
Short bowel syndrome 14% (6)
Hemoperitoneum 9.3% (4)
Catheter insertion site bleeding 
7% (3)
Incision site bleeding 7% (3)
16.3% 23% 
(10)
NS 18.6% (8)
0% 100% (8) 0% 100% (8) 100% (8) 0 Bleeding and flare at puncture 
site 25% (2)
Fever 25% (2)
Sepsis 25% (2)
0% 25% 
(2)
 NS 50% (4)
Table 2: (Continued)
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